China Pharma Holdings (CPHI) Current Deferred Revenue (2010 - 2026)
China Pharma Holdings (CPHI) posted Current Deferred Revenue of $153,642 for Q2 2026, up 97.8% from $77,683 a year earlier and up 148.8% from the prior quarter.
Powered by 
Analysis
China Pharma Holdings (CPHI) Current Deferred Revenue (2010 - 2026) Analysis & Trends
At the end of FY2025, China Pharma Holdings' Current Deferred Revenue came in at $111,580, down 31.2% from FY2024.
- Annual Current Deferred Revenue shows a five-year compound annual growth rate of -31.1% (FY2020 to FY2025).
- In prior years, China Pharma Holdings' Current Deferred Revenue was $162,208 in FY2024 (+79.2%), $90,507 in FY2023 (-82.6%), $520,295 in FY2022 (+147.7%) and $210,028 in FY2021 (-70.8%).
- The Q2 2026 figure stands as the highest quarterly Current Deferred Revenue since Q4 2024.
- On a year-over-year basis, Current Deferred Revenue increased in four of the last eight quarters, with growth averaging 47.3%.
- The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q3 2025, with growth of 385.2%; the weakest was Q3 2024, with a decline of 85.5%.
- According to Business Quant data, Current Deferred Revenue for the three prior quarters was $61,746 (Q1 2026), $111,580 (Q4 2025) and $120,912 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | China Pharma Holdings | 29.58 Mn | 28.46 Mn | 83,566.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 153,642.00 |
| Mar 31, 2026 | 61,746.00 |
| Dec 31, 2025 | 111,580.00 |
| Sep 30, 2025 | 120,912.00 |
| Jun 30, 2025 | 77,683.00 |
| Mar 31, 2025 | 114,435.00 |
| Dec 31, 2024 | 162,208.00 |
| Sep 30, 2024 | 24,920.00 |
| Jun 30, 2024 | 101,056.00 |
| Mar 31, 2024 | 112,357.00 |
| Dec 31, 2023 | 90,507.00 |
| Sep 30, 2023 | 172,110.00 |
| Jun 30, 2023 | 61,334.00 |
| Mar 31, 2023 | 136,681.00 |
| Dec 31, 2022 | 520,295.00 |
| Sep 30, 2022 | 84,048.00 |
| Jun 30, 2022 | 138,238.00 |
| Mar 31, 2022 | 136,099.00 |
| Dec 31, 2021 | 210,028.00 |
| Sep 30, 2021 | 420,039.00 |
API Access
China Pharma Holdings Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CPHI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "CPHI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CPHI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();